Adjuvant alternative cytokine-induced killer cell combined with natural killer cell immunotherapy improves the prognosis of post-mastectomy breast cancer

Adjuvant alternative cytokine-induced killer cell combined with natural killer cell immunotherapy improves the prognosis of post-mastectomy breast cancer

Breast cancer is one of the most common cancers in women. Triple-negative breast cancer (TNBC) has a significantly worse prognosis due to the lack of endocrine receptors including estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2). In this study, w...

Full description

Bibliographic Details
Main Authors: Xinyi Yang, Desheng Weng, Qiuzhong Pan, Tong Xiang, Chaopin Yang, Zhengrong Wu, Minxing Li, Songzuo Xie, Yan Tang, Jianchuan Xia, Jingjing Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Immunology
Subjects:
adjuvant cellular immunotherapy
breast cancer
natural killer cells
prognosis
cytokine-induced killer
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.974487/full

Similar Items

Similar Items